Perineuroma of the skin negative for S100 protein but positive for stem cell antigens: A possible stem cell tumor

Abstract

Perineuroma is a rare tumor originating from perineurium of the peripheral nerve. In contrast to neurofibroma and schwannoma, both of which arise from endoneurium and are immunohistochemically positive for S100 protein, perineuroma is negative for S100 protein; the fact makes the pathologic diagnosis difficult. As is well known, stem cells are highly associated with neuronal and organ developments in human embryos, and some neuronal cells are suspected to be derived from neuronal stem cells. Herein reported a very rare case of subcutaneous perineuroma negative for S100 protein but positive for a number of stem cell antigens; the case suggested that some perineuromas could arise from neuronal stem cells. A 68-year-old woman presented with a skin tumor of 10 mm in diameter in the foot. Physical examination revealed a small movable subcutaneous tumor, and resection was performed. Histologically, the tumor was a well-defined round tumor measuring 0.9 cm × 0.9 cm × 0.9 cm located in the subcutaneous tissue. No capsule was seen. The tumor was composed of hypocellular myxoid, neuroid tissues containing small areas of high cellularity where tumor cells resembled neuronal stem cells. Immunohistochemically, the tumor was negative for S100 protein, HMB-45, various cytokeratin (CK), EMA, α-SMA, desmin, p53, and many other antigens. The neuronal stem cell-like cells were positive for various stem cell antigens including NSE, KIT, bcl-2, chromogranin, synaptophysin, PDGFRA, MET, ErbB2, and CD34, as well as for vimentin and Ki-67 antigen (labeling index = 1.5%). Because the tumor was negative for S100 protein but positive for neuroendocrine molecules and neuronal stem cell antigens, the author diagnosed the tumor as perineuroma with stem cell features. Such a perineuroma has not been reported to date. The outcome of the patient was excellent.

Keywords

Perineuroma / S100 protein / Stem cells / Immunohistpochemistry

CONFLICTS OF INTEREST DISCLOSURE

The author declares no conflicts of interest.

References

[1] Pi-a-Oviedo S, Ortiz-Hidalgo C. The normal and neoplastic perineurium: a review. Adv Anat Pathol. 2008; 15: 147-64. PMid: 18434767. http://dx.doi.org/10.1097/PAP.0b013e31816f8519

[2] Hornick JL, Fletcher CD. Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol. 2005; 29: 845-58. http://dx.doi.org/10.1097/01.pas.0000155166.86409.d2

[3] Pitchford CW, Schwartz HS, Atkinson JB, et al. Soft tissue perineurioma in a patient with neurofibromatosis type 2: a tumor not previously associated with the NF2 syndrome. Am J Surg Pathol. 2006; 30: 1624-9. PMid: 17122521. http://dx.doi.org/10.1097/01.pas.0000213340.70852.d4

[4] Zamecnik M, Chlumska A. Perineurioma versus fibroblastic polyp of the colon. Am J Surg Pathol. 2006; 30: 1337-9. PMid: 17001168. http://dx.doi.org/10.1097/01.pas.0000213278.53338.7b

[5] Hornick JL, Fletcher CD. Intestinal perineuriomas: clinicopathologic definition of a new anatomic subset in a series of 10 cases. Am J Surg Pathol. 2005; 29: 859-65. http://dx.doi.org/10.1097/01.pas.0000154130.87219.2c

[6] Hornick JL, Bundock EA, Fletcher CD. Hybrid schwan-noma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors. Am J Surg Pathol. 2009; 33: 1554-61. PMid: 19623031. http://dx.doi.org/10.1097/PAS.0b013e3181accc6c

[7] Fetsch JF, Laskin WB, Hallman JR, et al. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information. Am J Surg Pathol. 2007; 31: 1103-14. PMid: 17592278. http://dx.doi.org/10.1097/PAS.0b013e31802d96af

[8] Fetsch JF, Laskin WB, Miettinen M. Nerve sheath myxoma: a clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate. Am J Surg Pathol. 2005; 29: 1615-24. PMid: 16327434. http://dx.doi.org/10.1097/01.pas.0000173025.87476.a4

[9] Pongpudpunth M, Bhawan J, Al-Natour SH, et al. Nestin-positive stem cells in neurofibromas from patients with neurofibromatosis type 1-tumorigenic or incidental? Am J Dermatopathol. 2010; 32: 574-7. PMid: 20520523. http://dx.doi.org/10.1097/DAD.0b013e3181cc8c7c

[10] Morris ZS, McClatchey AI. The neurofibroma cell of origin: SKPs expand the playing field. Cell Stem Cell. 2009; 4: 371-2. PMid: 19427284. http://dx.doi.org/10.1016/j.stem.2009.04.010

[11] Naldini L, Weidner KM, Vigna E, et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 1991; 10: 2867-78. PMid: 1655405.

[12] Hoch RV, Soriano P. Roles of PGDR in animal development. Development. 2003; 130: 4769-84. PMid: 12952899. http://dx.doi.org/10.1242/dev.00721

[13] Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene. 2006; 25: 3818-22. PMid: 16799623. http://dx.doi.org/10.1038/sj.onc.1209558

[14] Allison MR. Liver stem cells: implication for hepatocarcinogenesis. Stem cell Rev. 2005; 1: 253-60. http://dx.doi.org/10.1385/SCR:1:3:253

[15] Strain AJ, Crosby HA. Hepatic stem cells. Gut. 2000; 46: 743-50. http://dx.doi.org/10.1136/gut.46.6.743

[16] Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumor. Science. 1998; 279: 577-80. PMid: 9438854. http://dx.doi.org/10.1126/science.279.5350.577

[17] Cassiman D, Denef C, Desmet VJ, et al. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology. 2001; 33: 148-58. PMid: 11124831. http://dx.doi.org/10.1053/jhep.2001.20793

[18] Cassiman D, Libbrecht L, Sinelli N, et al. The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor 3. Am J Pathol. 2002; 161: 521-30. http://dx.doi.org/10.1016/S0002-9440(10)64208-3

[19] Sirica AE. Role of ErbB2 family receptor tyrosine kinase in intrahepatic cholangiocarcinoma. World J Gastroenterol. 2008; 14: 7033-58. PMid: 19084911. http://dx.doi.org/10.3748/wjg.14.7033

[20] Fabris L, Strazzabosco M, Crosby HA, et al. Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and bcl-2 from primary cholangiopathy and ductal plate malformations. Am J Pathol. 2000; 156: 1599-12. http://dx.doi.org/10.1016/S0002-9440(10)65032-8

[21] Cassiman D, Sinelli N, Bockx I, et al. Human hepatic progenitor cells express vasoactive intestinal peptide receptor type 2 and receive nerve endings. Liver Int. 2007; 27: 323-8. PMid: 17355452. http://dx.doi.org/10.1111/j.1478-3231.2006.01427.x

[22] Oben JA, Roskams T, Yang S, et al. Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury. Hepatology. 2003; 38: 664-73. http://dx.doi.org/10.1053/jhep.2003.50371

[23] Oben JA, Roskams T, Sinelli N, et al. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut. 2004; 53: 438-45. PMid: 14960531. http://dx.doi.org/10.1136/gut.2003.026658

[24] Ueno T, Tanikawa K. Intralobular innervation and lipocyte contractility in the liver. Nutrition. 1996; 13: 141-8. http://dx.doi.org/10.1016/S0899-9007(96)00389-9

[25] Ueno T, Bioulac-Sage P, Balabaud C, et al. Innervation of the sinusoidal wall: regulation of the sinusoidal diameter. Anat Rec. 2004; 280A: 868-73. PMid: 15382014. http://dx.doi.org/10.1002/ar.a.20092

[26] Bioulac-Sage P, Lafon ME, Saric J, et al. Nerves and perisinu-soidal cells in human liver. J Hepatol. 1990; 10: 105-12. http://dx.doi.org/10.1016/0168-8278(90)90080-B

[27] Cardinale V, Wang Y, Carpino G, et al. Mucin-producing cholan-giocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands. Hepatology. 2012; 55: 2041-2. PMid: 22262236. http://dx.doi.org/10.1002/hep.25587